⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22012711 | 0.88 | — | — | |
| SCHEMBL22012442 | 0.87 | — | — | |
| SCHEMBL22020706 | 0.86 | — | — | |
| SCHEMBL24978527 | 0.84 | CA2 (0.32) | — | |
| SCHEMBL21962387 | 0.84 | CA2 (0.32) | — | |
| SCHEMBL21962381 | 0.84 | CA2 (0.32) | — | |
| SCHEMBL22019987 | 0.79 | — | — | |
| SCHEMBL22013632 | 0.78 | — | — | |
| SCHEMBL22021436 | 0.77 | — | — | |
| SCHEMBL20681202 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230031406-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2023-02-02 | — | — | US | disclosed |
| WO-2020102096-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |